← Back to headlines
Cantor Fitzgerald Downgrades ADMA Biologics to Neutral
Cantor Fitzgerald has downgraded ADMA Biologics Inc. (ADMA) from an 'Overweight' rating to 'Neutral.' This change indicates a revised investment recommendation for the company's stock.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
